SCHEMBL3764628

SCHEMBL3764628

CC1(C)CC(=O)c2sc(N3CCOCC3)c(-c3ccnc(-c4cccc(CNS(C)(=O)=O)c4)c3)c2C1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKB Q96GD4 2/20 0.42
PIK3CD O00329 5/20 0.36
BUB1 O43683 1/20 0.36
JAK2 O60674 1/20 0.35
KDM1A O60341 1/20 0.34
HDAC1 Q13547 1/20 0.34
PIK3CA P42336 5/20 0.34
PIK3CB P42338 3/20 0.34
PIK3CG P48736 3/20 0.34
ENPP1 P22413 1/20 0.34
AURKA O14965 1/20 0.34
BRD4 O60885 3/20 0.33
USP2 O75604 1/20 0.33
LMNA P02545 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
MAPK1 P28482 1/20 0.33
HIF1A Q16665 1/20 0.33
CLK4 Q9HAZ1 1/20 0.33
GABRA1 P14867 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3761790 0.92 HDAC1 (0.37) AURKBPIK3CDBUB1JAK2KDM1A
SCHEMBL3764666 0.92 JAK2 (0.38) AURKBPIK3CDBUB1JAK2KDM1A
SCHEMBL3761533 0.89 KDM1A (0.40) AURKBPIK3CDBUB1JAK2KDM1A
SCHEMBL16161607 0.89 KDM1A (0.40) PIK3CDBUB1JAK2KDM1AHDAC1
SCHEMBL3759987 0.88 BUB1 (0.36) PIK3CDBUB1JAK2KDM1AHDAC1
SCHEMBL3760227 0.88 LRRK2 (0.40) PIK3CDBUB1PIK3CAPIK3CBPIK3CG
SCHEMBL3759307 0.88 MTOR (0.36) PIK3CDBUB1KDM1AHDAC1PIK3CA
SCHEMBL3760623 0.88 PSMB8 (0.41) PIK3CDBUB1JAK2PIK3CAPIK3CB
SCHEMBL3763765 0.87 AOC3 (0.38) PIK3CDBUB1PIK3CAPIK3CBPIK3CG
SCHEMBL3760242 0.86 PSMB8 (0.38) PIK3CDBUB1JAK2PIK3CAPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029570-B1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA SA (BE) 2014-10-15 EP disclosed
US-8324204-B2 Fused thiophene derivatives as kinase inhibitors UCB PHARMA SA (BE) 2012-12-04 US disclosed
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors PIKFYVE, PI4KA, PIK3CA AURKB 311/4885PIK3CD 9/4885BUB1 565/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.